Longevity Marketcap seeks to track and analyze the growing anti-aging biotechnology revolution by aggregating the financial data of the world’s longevity and regenerative medicine biotech companies.
By facilitating market intel we hope to more easily attract capital and awareness to the longevity industry, accelerating the advent of radical life extension.
The line between “normal” biotechnology companies and longevity stocks can be a bit blurry at times. There are many different aspects of biological aging that can be targeted. Furthermore, not all longevity companies market themselves as anti-aging companies, preferring to sell themselves as a pharmaceutical company that targets some age-related disease as a more practical investment thesis.
Generally, we consider any company that targets any of the “Hallmarks of the Biology of Aging”, age-related degenerative diseases, or develops regenerative biotechnology as part of the longevity biomedical revolution.
Nathan Cheng is an entrepreneur, biohacker, trader, and longevity evangelist based in Toronto, Canada. He is also the founder of Biohack Stack and Longevity List.
Formerly a Ph.D candidate in the Quantum Optics department @University of Toronto, he dropped out after a reckoning with existentialism. After years of wandering and soul searching, he discovered Aubrey de Grey and the burgeoning longevity field and has dedicated his life’s mission to the goal of ending aging.
Sign up for the LongevityMarketcap Newsletter below: